Patients on continuous antiplatelet therapy before gastrointestinal procedures or surgery did not have a higher risk of intra-operative or post-procedure bleeding, compared with those who did not use the drugs, researchers reported. Data from 17 of 22 studies that focused on surgeries and on endoscopic procedures performed mostly by gastroenterologists showed no statistically significant difference in bleeding risk between the groups.

Source: Continued Antiplatelet Therapy Does Not Boost Bleeding Risk in GI Procedures